The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against viral variants

Efi Makdasi, Anat Zvi, Ron Alcalay, Tal Noy-Porat, Eldar Peretz, Adva Mechaly, Yinon Levy, Eyal Epstein, Theodor Chitlaru, Ariel Tennenhouse, Moshe Aftalion, David Gur, Nir Paran, Hadas Tamir, Oren Zimhony, Shay Weiss, Michal Mandelboim, Ella Mendelson, Neta Zuckerman, Ital NemetLimor Kliker, Shmuel Yitzhaki, Shmuel C. Shapira, Tomer Israely, Sarel J. Fleishman, Ohad Mazor, Ronit Rosenfeld

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against viral variants'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds